fleroxacin (BioDeep_00000399071)
natural product
代谢物信息卡片
Fleroxacin (Quinodis)
化学式: C17H18F3N3O3 (369.13001940000004)
中文名称: 氟罗沙星
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1(=CN(C2=C(C1=O)C=C(C(=C2F)N3CCN(CC3)C)F)CCF)C(=O)O
InChI: InChI=1S/C17H18F3N3O3/c1-21-4-6-22(7-5-21)15-12(19)8-10-14(13(15)20)23(3-2-18)9-11(16(10)24)17(25)26/h8-9H,2-7H2,1H3,(H,25,26)
描述信息
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic
D004791 - Enzyme Inhibitors
同义名列表
2 个代谢物同义名
数据库引用编号
9 个数据库交叉引用编号
- ChEBI: CHEBI:31810
- KEGGdrug: D01716
- PubChem: 3357
- DrugBank: DB04576
- ChEMBL: CHEMBL6273
- MeSH: Fleroxacin
- CAS: 79660-53-0
- CAS: 79660-72-3
- MoNA: CCMSLIB00000078478
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Kazuo Furihata, Mitsuru Tashiro. Development of 1H{19F} saturation transfer difference experiments for detection of a fluorinated compound bound to proteins.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
2022 May; 38(5):825-829. doi:
10.1007/s44211-022-00098-3. [PMID: 35318618] - Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
Cell reports.
2021 04; 35(4):109040. doi:
10.1016/j.celrep.2021.109040. [PMID: 33910017] - Yankai Liu, Yajie Wang, Jingming Zhou, Yumei Chen, Hongliang Liu, Yanhua Qi, Luhui Zhao, Yuanyuan Zhang, Aiping Wang. Establishment of an immunological detection method of fleroxacin by fluorescence-linked immunosorbent assay.
Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.
2021 Apr; 38(4):594-601. doi:
10.1080/19440049.2021.1876251. [PMID: 33667148] - Kazuo Furihata, Mitsuru Tashiro. Identification of Binding Epitopes of a Fluorinated Compound Bound to Proteins Using 1H and 19F NMR Spectroscopy.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
2020 Jul; 36(7):881-883. doi:
10.2116/analsci.19n033. [PMID: 32037346] - Kai Li, Zhongling Liu, Yue Liu, Hanqi Zhang, Wei Yu. Collection and Separation of Fleroxacin and Ciprofloxacin in Ultrasound-Assisted Ionic Liquid Salting-Out Microextraction System.
Journal of chromatographic science.
2020 Jun; 58(6):576-584. doi:
10.1093/chromsci/bmaa021. [PMID: 32448888] - Tian-Yu Liu, Xiang-Long Qu, Bing Yan. A highly sensitive and selective 'turn-on' fluorescent probe for detection of fleroxacin in human serum and urine based on a lanthanide functionalized metal-organic framework.
Dalton transactions (Cambridge, England : 2003).
2019 Dec; 48(48):17945-17952. doi:
10.1039/c9dt03830b. [PMID: 31793573] - Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology.
2019 11; 96(5):629-640. doi:
10.1124/mol.119.115964. [PMID: 31515284] - Yuanyuan Jiao, Tae Hwan Kim, Xun Tao, Martina Kinzig, Cornelia B Landersdorfer, Stefanie K Drescher, Dhruvitkumar S Sutaria, Bartolome Moya, Ulrike Holzgrabe, Fritz Sörgel, Jürgen B Bulitta. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
2018 Oct; 123(?):416-428. doi:
10.1016/j.ejps.2018.07.054. [PMID: 30076955] - Cheng-yu Dong, Jia Xu, Shan-shan Zhou, Ying Liu. Spectroscopic and Molecular Modeling Studies on Binding of Fleroxacin with Human Serum Albumin.
Guang pu xue yu guang pu fen xi = Guang pu.
2017 Jan; 37(1):327-32. doi:
NULL. [PMID: 30222301] - Ying Xiao, Qing Wang, Yanmei Huang, Xiangling Ma, Xinnuo Xiong, Hui Li. Synthesis, structure, and biological evaluation of a copper(ii) complex with fleroxacin and 1,10-phenanthroline.
Dalton transactions (Cambridge, England : 2003).
2016 Jul; 45(27):10928-35. doi:
10.1039/c6dt00915h. [PMID: 27301999] - Huan Yu, Yanfei Tao, Dongmei Chen, Yuanhu Pan, Zhenli Liu, Yulian Wang, Lingli Huang, Menghong Dai, Dapeng Peng, Xu Wang, Zonghui Yuan. Simultaneous determination of fluoroquinolones in foods of animal origin by a high performance liquid chromatography and a liquid chromatography tandem mass spectrometry with accelerated solvent extraction.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2012 Feb; 885-886(?):150-9. doi:
10.1016/j.jchromb.2011.12.016. [PMID: 22230742] - Ai Jia, Yi Wan, Yang Xiao, Jianying Hu. Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant.
Water research.
2012 Feb; 46(2):387-94. doi:
10.1016/j.watres.2011.10.055. [PMID: 22118907] - H Malekinejad, A Nikibakhsh, S Gholizadeh-Soltani, A Farshid. Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis.
Indian journal of nephrology.
2012 Jan; 22(1):26-32. doi:
10.4103/0971-4065.91188. [PMID: 22279339] - Amit Arjyal, Buddha Basnyat, Samir Koirala, Abhilasha Karkey, Sabina Dongol, Krishna Kumar Agrawaal, Nikki Shakya, Kabina Shrestha, Manish Sharma, Sanju Lama, Kasturi Shrestha, Nely Shrestha Khatri, Umesh Shrestha, James I Campbell, Stephen Baker, Jeremy Farrar, Marcel Wolbers, Christiane Dolecek. Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial.
The Lancet. Infectious diseases.
2011 Jun; 11(6):445-54. doi:
10.1016/s1473-3099(11)70089-5. [PMID: 21531174] - Christos Chatzikyrkou, Iyas Hamwi, Christian Clajus, Jan Becker, Carsten Hafer, Jan T Kielstein. Biopsy proven acute interstitial nephritis after treatment with moxifloxacin.
BMC nephrology.
2010 Aug; 11(?):19. doi:
10.1186/1471-2369-11-19. [PMID: 20731847] - Manthena V S Varma, Bo Feng, R Scott Obach, Matthew D Troutman, Jonathan Chupka, Howard R Miller, Ayman El-Kattan. Physicochemical determinants of human renal clearance.
Journal of medicinal chemistry.
2009 Aug; 52(15):4844-52. doi:
10.1021/jm900403j. [PMID: 19445515] - X Jiang, J E Castelao, S Groshen, V K Cortessis, D Shibata, D V Conti, J-M Yuan, M C Pike, M Gago-Dominguez. Urinary tract infections and reduced risk of bladder cancer in Los Angeles.
British journal of cancer.
2009 Mar; 100(5):834-9. doi:
10.1038/sj.bjc.6604889. [PMID: 19174821] - Hanwen Sun, Liqing Li, Yuanyuan Wu. Capillary electrophoresis with electrochemiluminescence detection for simultaneous determination of proline and fleroxacin in human urine.
Drug testing and analysis.
2009 Feb; 1(2):87-92. doi:
10.1002/dta.22. [PMID: 20355181] - Jahye Kim, Hisakazu Ohtani, Masayuki Tsujimoto, Yasufumi Sawada. Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
Drug metabolism and pharmacokinetics.
2009; 24(2):167-74. doi:
10.2133/dmpk.24.167. [PMID: 19430173] - Weidong Qin, Qingchun Liu, Yongxia Fan. CE determination of quinolones in the presence of bovine serum albumin.
Journal of separation science.
2009 Jan; 32(1):118-24. doi:
10.1002/jssc.200800336. [PMID: 19035388] - Tao Ding, Dongxu Shen, Jinzhong Xu, Bin Wu, Huilan Chen, Chongyu Shen, Weijian Shen, Zengyun Zhao, Hongzhen Lian. [Simultaneous determination of 19 quinolone residues in honey using high performance liquid chromatography-tandem mass spectrometry].
Se pu = Chinese journal of chromatography.
2009 Jan; 27(1):34-8. doi:
". [PMID: 19449537] - Hirotaka Ando, Shigeru Izawa, Wataru Hori, Ippei Nakagawa. Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling.
Theoretical biology & medical modelling.
2008 Aug; 5(?):19. doi:
10.1186/1742-4682-5-19. [PMID: 18687151] - R Scott Obach, Franco Lombardo, Nigel J Waters. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Drug metabolism and disposition: the biological fate of chemicals.
2008 Jul; 36(7):1385-405. doi:
10.1124/dmd.108.020479. [PMID: 18426954] - Lun Wang, Ping Yang, Yongxin Li, Hongqi Chen, Maoguo Li, Fabao Luo. A flow injection chemiluminescence method for the determination of fluoroquinolone derivative using the reaction of luminol and hydrogen peroxide catalyzed by gold nanoparticles.
Talanta.
2007 May; 72(3):1066-72. doi:
10.1016/j.talanta.2006.12.050. [PMID: 19071726] - Gen-Hua Wu, Jie Wang, Chang Guo, Dong-Xiang Wang, Ting-Ting Zhao. [Study on the ternary complex of FLRX, zinc(II) and BSA by the method of fluorescence].
Guang pu xue yu guang pu fen xi = Guang pu.
2007 Apr; 27(4):765-8. doi:
NULL. [PMID: 17608194] - Shiwang Liu, Li-Wei Zhang, Xin-Xiang Zhang. Interaction between fluoroquinolones and bovine serum albumin studied by affinity capillary electrophoresis.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
2006 Dec; 22(12):1515-8. doi:
10.2116/analsci.22.1515. [PMID: 17159308] - Ping Li. [Clinical observation on shufei granule in improving right ventricular function of patients with chronic pulmonary heart disease].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
2006 Aug; 26(8):732-5. doi:
". [PMID: 16970099] - Myo-Kyoung Kim, Charles Nightingale, David Nicolau. Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.
Clinical pharmacokinetics.
2003; 42(11):985-96. doi:
10.2165/00003088-200342110-00004. [PMID: 12908854] - Tomoko Yazaki, Yuji Yoshiyama, Paul Wong, Denis Beauchamp, Motoko Kanke. Protective effect of fleroxacin against the nephrotoxicity of isepamicin in rats.
Biological & pharmaceutical bulletin.
2002 Apr; 25(4):516-9. doi:
10.1248/bpb.25.516. [PMID: 11995935] - P Djurdjevic, M Jelikic-Stankov, A Laban. High-performance liquid chromatographic assay of fleroxacin in human serum using fluorescence detection.
Talanta.
2001 Sep; 55(3):631-8. doi:
10.1016/s0039-9140(01)00471-4. [PMID: 18968409] - R Thiel, S Metzner, C Gericke, U Rahm, R Stahlmann. Effects of fluoroquinolones on the locomotor activity in rats.
Archives of toxicology.
2001 Mar; 75(1):36-41. doi:
10.1007/s002040000207. [PMID: 11357519] - M Rizk, F Belal, F Ibrahim, S Ahmed, N M El-Enany. Voltammetric analysis of certain 4-quinolones in pharmaceuticals and biological fluids.
Journal of pharmaceutical and biomedical analysis.
2000 Dec; 24(2):211-8. doi:
10.1016/s0731-7085(00)00401-5. [PMID: 11130200] - E C de Lange, S Marchand, D van den Berg, I C van der Sandt, A G de Boer, A Delon, S Bouquet, W Couet. In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
2000 Dec; 12(2):85-93. doi:
10.1016/s0928-0987(00)00149-4. [PMID: 11102735] - C M Chukwuani, H A Coker, A M Oduola, A Sowunmi, N D Ifudu. Bioavailability of ciprofloxacin and fleroxacin: results of a preliminary investigation in healthy adult Nigerian male volunteers.
Biological & pharmaceutical bulletin.
2000 Aug; 23(8):968-72. doi:
10.1248/bpb.23.968. [PMID: 10963305] - E J Begg, R A Robson, D A Saunders, G G Graham, R C Buttimore, A M Neill, G I Town. The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing.
British journal of clinical pharmacology.
2000 Jan; 49(1):32-8. doi:
10.1046/j.1365-2125.2000.00105.x. [PMID: 10606835] - A Kawada, K Hatanaka, H Gomi, I Matsuo. In vitro phototoxicity of new quinolones: production of active oxygen species and photosensitized lipid peroxidation.
Photodermatology, photoimmunology & photomedicine.
1999 Dec; 15(6):226-30. doi:
10.1111/j.1600-0781.1999.tb00094.x. [PMID: 10599972] - M Zhao, S Jiang, R Wang. [The serum bactericidal activity of domestic fleroxacin and lomefloxacin].
Zhonghua nei ke za zhi.
1999 Feb; 38(2):98-100. doi:
NULL. [PMID: 11798634] - C M Chukwuani, H A Coker, A M Oduola, N D Ifudu, A Sowunmi. Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers.
Chemotherapy.
1998 Nov; 44(6):369-76. doi:
10.1159/000007146. [PMID: 9755295] - E Rey, J M Tréluyer, G Pons. Drug disposition in cystic fibrosis.
Clinical pharmacokinetics.
1998 Oct; 35(4):313-29. doi:
10.2165/00003088-199835040-00004. [PMID: 9812180] - M Jelikic-Stankov, J Odovic, D Stankov, P Djurdjevic. Determination of fleroxacin in human serum and in dosage forms by derivative UV spectrophotometry.
Journal of pharmaceutical and biomedical analysis.
1998 Oct; 18(1-2):145-50. doi:
10.1016/s0731-7085(98)00151-4. [PMID: 9863952] - M Kimura, J Fujiyama, A Nagai, M Hirayama, M Kuriyama. [Encephalopathy induced by fleroxacin in a patient with Machado-Joseph disease].
Rinsho shinkeigaku = Clinical neurology.
1998 Sep; 38(9):846-8. doi:
. [PMID: 10078039] - M Tsugawa, K Monden, Y Nasu, H Kumon, H Ohmori. Prospective randomized comparative study of antibiotic prophylaxis in urethrocystoscopy and urethrocystography.
International journal of urology : official journal of the Japanese Urological Association.
1998 Sep; 5(5):441-3. doi:
10.1111/j.1442-2042.1998.tb00384.x. [PMID: 9781431] - K G Naber, U Theuretzbacher, M Kinzig, O Savov, F Sörgel. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
Antimicrobial agents and chemotherapy.
1998 Jul; 42(7):1659-65. doi:
10.1128/aac.42.7.1659. [PMID: 9661000] - C Förster, M Rücker, M Shakibaei, I Baumann-Wilschke, J Vormann, R Stahlmann. Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures.
Archives of toxicology.
1998 Jun; 72(7):411-9. doi:
10.1007/s002040050521. [PMID: 9708880] - K G Naber, M Well, K Hollauer, D Kirchbauer, W Witte. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
Chemotherapy.
1998 Mar; 44(2):77-84. doi:
10.1159/000007096. [PMID: 9551236] - J Viitanen, K Malminiemi, J Kallio, V M Puolakka, P Rajala, T L Tammela. Transurethral prostatectomy in patients with preoperative bacteriuria: double-blind study with oral fleroxacin and cefalexin.
Chemotherapy.
1998 Jan; 44(1):69-75. doi:
10.1159/000007093. [PMID: 9444412] - N Hobara, H Kameya, N Hokama, S Ohshiro, M Sakanashi. Rapid and simple determination of fleroxacin in rat plasma using a solid-phase extraction column.
Journal of chromatography. B, Biomedical sciences and applications.
1997 Dec; 703(1-2):279-83. doi:
10.1016/s0378-4347(97)00409-x. [PMID: 9448088] - T Deguchi, M Yasuda, M Nakano, S Ozeki, E Kanematsu, H Fukuda, S Maeda, I Saito, Y Kawada. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Chemotherapy.
1997 Jul; 43(4):239-44. doi:
10.1159/000239573. [PMID: 9209780] - D Beauchamp, G Laurent, L Grenier, P Gourde, J Zanen, J A Heuson-Stiennon, M G Bergeron. Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin.
Antimicrobial agents and chemotherapy.
1997 Jun; 41(6):1237-45. doi:
10.1128/aac.41.6.1237. [PMID: 9174177] - G Klecak, F Urbach, H Urwyler. Fluoroquinolone antibacterials enhance UVA-induced skin tumors.
Journal of photochemistry and photobiology. B, Biology.
1997 Feb; 37(3):174-81. doi:
10.1016/s1011-1344(96)07424-6. [PMID: 9085564] - C Förster, R Schwabe, E Lozo, U Zippel, J Vormann, T Günther, H J Merker, R Stahlmann. Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics.
Archives of toxicology.
1997; 72(1):26-32. doi:
10.1007/s002040050464. [PMID: 9458187] - M Müller, O Haag, T Burgdorff, A Georgopoulos, W Weninger, B Jansen, G Stanek, H Pehamberger, E Agneter, H G Eichler. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans.
Antimicrobial agents and chemotherapy.
1996 Dec; 40(12):2703-9. doi:
10.1128/aac.40.12.2703. [PMID: 9124826] - F Fuentes, M M Martín, J Izquierdo, M L Gomez-Lus, J Prieto. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
Chemotherapy.
1996 Sep; 42(5):354-62. doi:
10.1159/000239467. [PMID: 8874975] - D E Uehlinger, F Schaedeli, M Kinzig, F Sörgel, F J Frey. Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis.
Antimicrobial agents and chemotherapy.
1996 Aug; 40(8):1903-9. doi:
10.1128/aac.40.8.1903. [PMID: 8843301] - T C Gasser, M Wisard, R Frei. Oral fleroxacin prophylaxis in transurethral surgery.
The Journal of urology.
1996 Jul; 156(1):146-8. doi:
. [PMID: 8648777] - J C Hall, K J Christiansen, P England, A I Low, P J McRae, J Mander, T A Taylor, J L Hall. Antibiotic prophylaxis for patients undergoing transurethral resection of the prostate.
Urology.
1996 Jun; 47(6):852-6. doi:
10.1016/s0090-4295(96)00066-0. [PMID: 8677576] - T Ooie, H Suzuki, T Terasaki, Y Sugiyama. Characterization of the transport properties of a quinolone antibiotic, fleroxacin, in rat choroid plexus.
Pharmaceutical research.
1996 Apr; 13(4):523-7. doi:
10.1023/a:1016081618149. [PMID: 8710740] - H Giamarellou. Fleroxacin in complicated urinary tract infections.
Chemotherapy.
1996 Mar; 42 Suppl 1(?):17-27. doi:
10.1159/000239488. [PMID: 8861531] - K G Naber. Fleroxacin overview.
Chemotherapy.
1996 Mar; 42 Suppl 1(?):1-9. doi:
10.1159/000239485. [PMID: 8861529] - C E Edmiston, E C Suarez, A P Walker, M P Demeure, C T Frantzides, W J Schulte, S D Wilson. Penetration of ciprofloxacin and fleroxacin into biliary tract.
Antimicrobial agents and chemotherapy.
1996 Mar; 40(3):787-91. doi:
10.1128/aac.40.3.787. [PMID: 8851613] - T Yamamoto, H Kusajima, M Hosaka, H Shinoda. Uptake and intracellular activity of fleroxacin in phagocytic cells.
Chemotherapy.
1995 Sep; 41(5):353-9. doi:
10.1159/000239367. [PMID: 8521737] - H Sagara, I Tomizawa, Y Takizawa, Y Nitta, T Tsunoda, T Yamaguchi, G Masuda, M Negishi, A Ajisawa, M Murata. [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis].
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.
1994 Nov; 68(11):1390-408. doi:
10.11150/kansenshogakuzasshi1970.68.1390. [PMID: 7829908] - J Schrenzel, F Cerruti, M Herrmann, T Leemann, E Weidekamm, R Portmann, B Hirschel, D P Lew. Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
Antimicrobial agents and chemotherapy.
1994 Jun; 38(6):1219-24. doi:
10.1128/aac.38.6.1219. [PMID: 8092817] - A Pefanis, C Thauvin-Eliopoulos, J Holden, G M Eliopoulos, M J Ferraro, R C Moellering. Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscesses.
Antimicrobial agents and chemotherapy.
1994 Feb; 38(2):252-5. doi:
10.1128/aac.38.2.252. [PMID: 8192453] - A J Szuna, R W Blain. Determination of a new antibacterial agent (Ro 23-9424) by multidimensional high-performance liquid chromatography with ultraviolet detection and direct plasma injection.
Journal of chromatography.
1993 Oct; 620(2):211-6. doi:
10.1016/0378-4347(93)80006-p. [PMID: 8300788] - J Schrenzel, P Dayer, T Leemann, E Weidekamm, R Portmann, D P Lew. Influence of rifampin on fleroxacin pharmacokinetics.
Antimicrobial agents and chemotherapy.
1993 Oct; 37(10):2132-8. doi:
10.1128/aac.37.10.2132. [PMID: 8257135] - A J Fischman, E Livni, J Babich, N M Alpert, Y Y Liu, E Thom, R Cleeland, B L Prosser, J A Correia, H W Strauss. Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography.
Antimicrobial agents and chemotherapy.
1993 Oct; 37(10):2144-52. doi:
10.1128/aac.37.10.2144. [PMID: 8257137] - H Hummler, W F Richter, A G Hendrickx. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
Toxicology and applied pharmacology.
1993 Sep; 122(1):34-45. doi:
10.1006/taap.1993.1169. [PMID: 8397453] - J Guinea, M Robert, D Gargallo-Viola, M A Xicota, J Garcia, E Tudela, M Esteve, R Coll, M Pares, R Roser. In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent.
Antimicrobial agents and chemotherapy.
1993 Apr; 37(4):868-74. doi:
10.1128/aac.37.4.868. [PMID: 8388202] - C E Cox. Comparison of intravenous fleroxacin with ceftazidime for treatment of complicated urinary tract infections.
The American journal of medicine.
1993 Mar; 94(3A):118S-125S. doi:
. [PMID: 8452167] - E Weidekamm. Pharmacokinetics of fleroxacin in renal impairment.
The American journal of medicine.
1993 Mar; 94(3A):70S-74S. doi:
. [PMID: 8452185] - E Weidekamm, R Portmann. Penetration of fleroxacin into body tissues and fluids.
The American journal of medicine.
1993 Mar; 94(3A):75S-80S. doi:
NULL. [PMID: 8452186] - C H Nightingale. Overview of the pharmacokinetics of fleroxacin.
The American journal of medicine.
1993 Mar; 94(3A):38S-43S. doi:
10.1016/s0002-9343(20)31138-4. [PMID: 8452184] - W Ulmer. Fleroxacin versus amoxicillin in the treatment of acute exacerbation of chronic bronchitis.
The American journal of medicine.
1993 Mar; 94(3A):136S-141S. doi:
10.1016/s0002-9343(20)31154-2. [PMID: 8452170] - D W Morck, M E Olson, S G McKay, K Lam, B Prosser, R Cleeland, J W Costerton. Therapeutic efficacy of fleroxacin for eliminating catheter-associated urinary tract infection in a rabbit model.
The American journal of medicine.
1993 Mar; 94(3A):23S-30S. doi:
NULL. [PMID: 8452182] - M Dan, E Weidekamm, R Sagiv, R Portmann, H Zakut. Penetration of fleroxacin into breast milk and pharmacokinetics in lactating women.
Antimicrobial agents and chemotherapy.
1993 Feb; 37(2):293-6. doi:
10.1128/aac.37.2.293. [PMID: 8452360] - G L Kearns. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.
The Annals of pharmacotherapy.
1993 Jan; 27(1):74-9. doi:
10.1177/106002809302700117. [PMID: 8431626] - T J Lubowski, C H Nightingale, K Sweeney, R Quintiliani. Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteers.
Antimicrobial agents and chemotherapy.
1992 Dec; 36(12):2758-60. doi:
10.1128/aac.36.12.2758. [PMID: 1482143] - P H Edelstein, M A Edelstein, B Holzknecht. In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
Antimicrobial agents and chemotherapy.
1992 Nov; 36(11):2387-91. doi:
10.1128/aac.36.11.2387. [PMID: 1489182] - M Young, R E Hancock. Fluoroquinolone supersusceptibility mediated by outer membrane protein OprH overexpression in Pseudomonas aeruginosa: evidence for involvement of a nonporin pathway.
Antimicrobial agents and chemotherapy.
1992 Nov; 36(11):2365-9. doi:
10.1128/aac.36.11.2365. [PMID: 1336943] - A J Fischman, E Livni, J Babich, N M Alpert, Y Y Liu, E Thom, R Cleeland, B L Prosser, R J Callahan, J A Correia. Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography.
Antimicrobial agents and chemotherapy.
1992 Oct; 36(10):2286-92. doi:
10.1128/aac.36.10.2286. [PMID: 1444310] - R A Blouin, B A Hamelin, D A Smith, T S Foster, W J John, H A Welker. Fleroxacin pharmacokinetics in patients with liver cirrhosis.
Antimicrobial agents and chemotherapy.
1992 Mar; 36(3):632-8. doi:
10.1128/aac.36.3.632. [PMID: 1622175] - T J Lubowski, C Nightingale, K Sweeney, R Quintiliani, J Zhi. Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.
Antimicrobial agents and chemotherapy.
1992 Mar; 36(3):651-5. doi:
10.1128/aac.36.3.651. [PMID: 1622179] - A E Stuck, D K Kim, F J Frey. Fleroxacin clinical pharmacokinetics.
Clinical pharmacokinetics.
1992 Feb; 22(2):116-31. doi:
10.2165/00003088-199222020-00003. [PMID: 1551289] - A Georgopoulos, S M Feistauer, W Graninger, S Pfleger, M Georgopoulos. Antibacterial activity of sparfloxacin against experimental renal infections in mice.
Antimicrobial agents and chemotherapy.
1992 Feb; 36(2):505-7. doi:
10.1128/aac.36.2.505. [PMID: 1318685] - R Portmann, E Weidekamm. Penetration of fleroxacin into human and animal tissues.
Chemotherapy.
1992; 38(3):145-9. doi:
10.1159/000238954. [PMID: 1511632] - M Cakmakci, L Gossweiler, J Schilling, R Schlumpf, S Geroulanos. Penetration of fleroxacin into human lung, muscle, and fat tissue.
Drugs under experimental and clinical research.
1992; 18(7):299-302. doi:
NULL. [PMID: 1295723] - M H Miller, A Madu, G Samathanam, D Rush, C N Madu, K Mathisson, M Mayers. Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits.
Antimicrobial agents and chemotherapy.
1992 Jan; 36(1):32-8. doi:
10.1128/aac.36.1.32. [PMID: 1590696] - N Keller, G Raponi, I M Hoepelman, B P Overbeek, M Rozenberg-Arska, J Verhoef. Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes.
Zentralblatt fur Bakteriologie : international journal of medical microbiology.
1991 Jan; 274(4):519-26. doi:
10.1016/s0934-8840(11)80090-3. [PMID: 1907453] - W L Hayton, V Vlahov, N Bacracheva, I Viachki, R Portmann, G Muirhead, K Stoeckel, E Weidekamm. Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patients.
Antimicrobial agents and chemotherapy.
1990 Dec; 34(12):2375-80. doi:
10.1128/aac.34.12.2375. [PMID: 2128442] - P Jynge, T Skjetne, I Gribbestad, C H Kleinbloesem, H F Hoogkamer, O Antonsen, J Krane, O E Bakøy, K M Furuheim, O G Nilsen. In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans.
Clinical pharmacology and therapeutics.
1990 Nov; 48(5):481-9. doi:
10.1038/clpt.1990.183. [PMID: 2121409] - J C Akaniro, C E Vidaurre, H R Stutman, M I Marks. Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.
Antimicrobial agents and chemotherapy.
1990 Oct; 34(10):1880-4. doi:
10.1128/aac.34.10.1880. [PMID: 2127170] - J G Christenson, K K Chan, R Cleeland, B Dix-Holzknecht, H H Farrish, I H Patel, A Specian. Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.
Antimicrobial agents and chemotherapy.
1990 Oct; 34(10):1895-900. doi:
10.1128/aac.34.10.1895. [PMID: 2127171] - J P Fillastre, A Leroy, B Moulin, M Dhib, F Borsa-Lebas, G Humbert. Pharmacokinetics of quinolones in renal insufficiency.
The Journal of antimicrobial chemotherapy.
1990 Oct; 26 Suppl B(?):51-60. doi:
10.1093/jac/26.suppl_b.51. [PMID: 2124213] - H Lode, G Höffken, M Boeckk, N Deppermann, K Borner, P Koeppe. Quinolone pharmacokinetics and metabolism.
The Journal of antimicrobial chemotherapy.
1990 Oct; 26 Suppl B(?):41-9. doi:
10.1093/jac/26.suppl_b.41. [PMID: 2124212] - F Taga, F Kobayashi, S Saito, T Ooie, F Kawahara, H Uchida, J Shimada, S Hori, O Sakai. Possibility for induction of convulsion by fleroxacin and its disposition in the central nervous system in animals.
Arzneimittel-Forschung.
1990 Aug; 40(8):900-4. doi:
. [PMID: 2173611] - A M Taburet, A Devillers, P Thomare, J P Fillastre, P Veyssier, E Singlas. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.
Clinical pharmacokinetics.
1990 Jul; 19(1):80-8. doi:
10.2165/00003088-199019010-00006. [PMID: 2116257] - E Singlas, A Leroy, E Sultan, M Godin, B Moulin, A M Taburet, M Dhib, J P Fillastre. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis.
Clinical pharmacokinetics.
1990 Jul; 19(1):67-79. doi:
10.2165/00003088-199019010-00005. [PMID: 2116256] - M Parent, M St-Laurent, M LeBel. Safety of fleroxacin coadministered with theophylline to young and elderly volunteers.
Antimicrobial agents and chemotherapy.
1990 Jun; 34(6):1249-53. doi:
10.1128/aac.34.6.1249. [PMID: 2118328]